NanoTalks by Curapath is your gateway to the future of healthcare nanotechnology. In each episode, we explore the latest trends in lipid and polymer nanoparticles a groundbreaking field transforming how next-generation therapies and vaccines are developed. Discover how these tiny, multifunctional structures can enhance treatment effectiveness, minimize side effects, and open the door to innovations that once seemed out of reach. Join us as we delve into cutting-edge research, clinical insights, and the major advances shaping modern medicine
Hot topics
NanoTalks
Polymer Drug Conjugates Explained
Explore how polymer–drug conjugates (PDCs) are transforming targeted drug delivery by improving solubility, extending circulation time, and enabling controlled, site-specific release of therapeutic payloads.
This article explores the evolution of PDCs from early PEGylated systems to next-generation platforms based on PEG alternatives, anionic polyelectrolytes such as poly(glutamic acid) (PGA), and polypeptide-based polymers, highlighting their clinical relevance, GMP readiness, and role in advancing modern small-molecule and biologic therapies.
.jpg?width=1603&height=1080&name=fotos%20blog%20(1).jpg)
Keep exploring Curapath Blog , there is more NanoTalks yet to explore
Recent Articles
Nanoparticle-based drug delivery has revolutionized how therapeutics can be transported and released within the human...
Process Performance Qualification (PPQ) is a critical part of the pharmaceutical manufacturing validation lifecycle,...
Currently, lipid nanoparticles (LNPs) stand as the predominant delivery system for emerging mRNA-based therapeutic...
As RNA-based therapeutics continue to revolutionize modern medicine, lipid nanoparticles (LNPs) have emerged as the...
Peptides have emerged as promising therapeutic agents due to their high specificity and biocompatibility. However,...